IBDEI1L3 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25676,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,25676,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,25676,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,25677,0)
 ;;=F16.94^^92^1172^6
 ;;^UTILITY(U,$J,358.3,25677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25677,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,25677,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,25677,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,25678,0)
 ;;=F16.159^^92^1172^7
 ;;^UTILITY(U,$J,358.3,25678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25678,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,25678,1,4,0)
 ;;=4^F16.159
 ;;^UTILITY(U,$J,358.3,25678,2)
 ;;=^5003331
 ;;^UTILITY(U,$J,358.3,25679,0)
 ;;=F16.259^^92^1172^8
 ;;^UTILITY(U,$J,358.3,25679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25679,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,25679,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,25679,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,25680,0)
 ;;=F16.959^^92^1172^9
 ;;^UTILITY(U,$J,358.3,25680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25680,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,25680,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,25680,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,25681,0)
 ;;=F16.99^^92^1172^17
 ;;^UTILITY(U,$J,358.3,25681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25681,1,3,0)
 ;;=3^Hallucinogen Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,25681,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,25681,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,25682,0)
 ;;=F16.983^^92^1172^16
 ;;^UTILITY(U,$J,358.3,25682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25682,1,3,0)
 ;;=3^Hallucinogen Persisting Perception D/O
 ;;^UTILITY(U,$J,358.3,25682,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,25682,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,25683,0)
 ;;=F16.21^^92^1172^20
 ;;^UTILITY(U,$J,358.3,25683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25683,1,3,0)
 ;;=3^Hallucinogen Use DO,Mod/Sev,In Remiss
 ;;^UTILITY(U,$J,358.3,25683,1,4,0)
 ;;=4^F16.21
 ;;^UTILITY(U,$J,358.3,25683,2)
 ;;=^5003337
 ;;^UTILITY(U,$J,358.3,25684,0)
 ;;=F16.11^^92^1172^18
 ;;^UTILITY(U,$J,358.3,25684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25684,1,3,0)
 ;;=3^Hallucinogen Use DO,Mild,In Remiss
 ;;^UTILITY(U,$J,358.3,25684,1,4,0)
 ;;=4^F16.11
 ;;^UTILITY(U,$J,358.3,25684,2)
 ;;=^268239
 ;;^UTILITY(U,$J,358.3,25685,0)
 ;;=F11.10^^92^1173^25
 ;;^UTILITY(U,$J,358.3,25685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25685,1,3,0)
 ;;=3^Opioid Use DO,Mild,Uncomp
 ;;^UTILITY(U,$J,358.3,25685,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,25685,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,25686,0)
 ;;=F11.129^^92^1173^22
 ;;^UTILITY(U,$J,358.3,25686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25686,1,3,0)
 ;;=3^Opioid Intox w/o Perceptual Dists w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,25686,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,25686,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,25687,0)
 ;;=F11.14^^92^1173^5
 ;;^UTILITY(U,$J,358.3,25687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25687,1,3,0)
 ;;=3^Opioid Induced Depressive D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,25687,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,25687,2)
 ;;=^5003119
